The SternaLock® System from Biomet Microfixation, applies the proven principles of Locking Rigid Fixation to sternal closure, resulting in an optimal closure method for those patients who are at high risk for sternal wound infections.

The American Heart Association reports that each year in the United States, over 690,000 open-heart surgeries are performed requiring mid-line sternotomies. Studies have shown that thousands of these patients will develop mediastinitis or other deep sternal-wound infections. These complications present multiple disadvantages to both the patient and the hospital, including significantly increasing patient mortality rates.

Benefits of the SternaLock System include: Decreased rate of infection^;Greater stability Ea;rlier bone healing ;Increased patient comfort^;Reduced sternal clicking

Indications：The Biomet Microfixation SternaLock® system is a Sternal Closure System that is intended for use in the stabilization and fixation of fractures of the anterior chest wall. This includes sternal fixation following sternotomy and sternal reconstructive surgical procedures to aid in the alignment and stabilization of bone. Instrumentation has been designed specifically for use with this system of implants.

The SternaLock system is designed to address sternal-wound infection in patients that fall within the high-risk population. High risk is determined by several pre-operative and intra-operative risk factors including:

Risk Factors: Chronic obstructive pulmonary disorder ;Diabetes;Immune compromise ;Obesity ；Off-midline sternotomy ；Osteoporosis ；Renal failure ；Transverse fractures of the sternum;Re-operative surgery;Chronic steroid use ;Concurrent infection.